The CANS-MCI, a computer administered, scored, and interpreted touch screen battery, was evaluated for its ability to screen for mild cognitive impairment. 310 community-dwelling elders enrolled in an NIA-funded study. One-month test-retest reliability correlations were all significant (p<.05-p<.001). Concurrent validity correlations were all significant (p<.001). A high level of diagnostic validity was attained relative to the WMS-R LMS-II test (p<.001). Confirmatory factor analysis supported a three-factor model indicating the tests measure the intended cognitive dimensions of Memory, Language/Spatial Fluency, and Executive Function/Mental Control. Goodness of fit indicators were strong (Bentler Comparative Fit Index = .99; Root Mean Square Error of Approximation=.055). Initial validation analyses indicate that the CANS-MCI shows promise of being a reliable, valid screening tool to determine whether more intensive testing for early cognitive impairment is warranted.
Published in final edited form as: J Neuropsychiatry Clin Neurosci. 2005; 17(1): 98–105.[/spb_text_block] [impact_text include_button=”yes” button_style=”standard” title=”Read the article” href=”http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559991/” color=”accent” target=”_blank” position=”cta_align_right” alt_background=”none” width=”1/1″ el_position=”first last”]
Open the article at the US National Library of Medicine website.[/impact_text]